SIA
ZBH icon

Strategic Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Strategic Investment Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,641
Closed -$802K – 196
2021
Q3 		$802K Buy
5,641
+785
+16% +$115K 0.18% 120
2021
Q2 		$758K Buy
4,856
+2,055
+73% +$333K 0.17% 119
2021
Q1 		$435K Buy
+2,801
New +$434K 0.11% 149

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Strategic Investment Advisors's ZBH Position: Q4 2021 in Review

Strategic Investment Advisors sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 5,641 shares — an estimated $802K sold.

Strategic Investment Advisors first reported a position in ZBH in Q1 2021 and held it in 3 quarters. The position peaked at $802K in Q3 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Strategic Investment Advisors reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Strategic Investment Advisors sold 5,641 Zimmer Biomet shares in Q4 2021, an estimated $802K.
  • Strategic Investment Advisors first reported a position in Zimmer Biomet in Q1 2021 and held it in 3 quarters.
  • Strategic Investment Advisors's Zimmer Biomet position peaked at $802K in Q3 2021.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Strategic Investment Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.